You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Warmuth Markus · SEC Form 4 · Filed Jul 17, 2026
Sale
Calculated transaction value
$220.22K
Warmuth Markus President & CEO
GLUE
Transaction date
Jul 16, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$23.16
Jul 16, 2026
First close after public filing
$23.48
Jul 20, 2026
30-day return after filing
-34.5%
Through Aug 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,500 shares @ $23.18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-307791
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$220.22K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Jul 16, 2026 | $220.22K |